Sell Satyam, target of Rs 150: Anand Rathi

Published on Wed, Dec 31, 2008 at 10:10 |  Source : Moneycontrol.com

Updated at Wed, Dec 31, 2008 at 10:13  

137127 Investors following Mahindra Satyam. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Anand Rathi Securities has recommended a sell rating on Satyam Computer Services with a target price of Rs 150 in its December 31, 2008 research report. "Besides a share buy-back, Satyam Computers will consider: 1) strengthening the governance structure, including the size of the board and altering its composition; 2) strategic options to enhance shareholder value 3) addressing issues arising from a possible dilution of the promoter's stake."

"There is a high probability of management change since the promoter stake  (already low at 8.6% in Sep '08) has been reduced in the last week. Four independent directors have quit the board after investors questioned the propriety of using company's cash to buy two firms linked to the promoter. Sell, target of Rs 150," says Anand Rathi's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......

  

More on Moneycontrol

Trending News

Business News

Apple rushing to finalize apps for iPad 3 announcement
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com